Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR-positive breast cancer

SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR...

SABCS 2016: Genomic sequencing of treatment-resistant metastatic breast cancer reveals clinically relevant genetic alterations

SABCS 2016: Genomic sequencing of treatment-resistant metastatic breast cancer reveals clinically relevant genetic...

ASH 2016: Additions to standard multiple myeloma therapy do not appear to yield additional benefit

ASH 2016: Additions to standard multiple myeloma therapy do not appear to yield additional benefit

ASH 2016: IKZF1 mutations found to increase hereditary risk for ALL in children

ASH 2016: IKZF1 mutations found to increase hereditary risk for ALL in children

ASH 2016: Nivolumab with chemotherapy improves response, survival in AML study patients

ASH 2016: Nivolumab with chemotherapy improves response, survival in AML study patients

ASH 2016 : Reducing or stopping TKI for CML can be safe, beneficial for some patients

ASH 2016 : Reducing or stopping TKI for CML can be safe, beneficial for some patients

ASH 2016: New CAR-T treatment holds promise for children and young adults with hard-to-treat leukaemia

ASH 2016: New CAR-T treatment holds promise for children and young adults with hard-to-treat leukaemia

Disabling critical 'node' revs up attack when cancer immunotherapies fall short

Disabling critical 'node' revs up attack when cancer immunotherapies fall short

Study reveals new role for Hippo pathway in suppressing cancer immunity

Study reveals new role for Hippo pathway in suppressing cancer immunity

Proposed biosimilar drug shows potential as breast cancer treatment

Proposed biosimilar drug shows potential as breast cancer treatment

More from ecancer